TY - JOUR
T1 - Immediate unselected coronary angiography versus delayed triage in survivors of out-of-hospital cardiac arrest without ST-segment elevation
T2 - Design and rationale of the TOMAHAWK trial
AU - Desch, Steffen
AU - Freund, Anne
AU - Graf, Tobias
AU - Fichtlscherer, Stephan
AU - Haake, Hendrik
AU - Preusch, Michael
AU - Hammer, Fabian
AU - Akin, Ibrahim
AU - Christ, Martin
AU - Liebetrau, Christoph
AU - Skurk, Carsten
AU - Steiner, Stephan
AU - Voigt, Ingo
AU - Schmitz, Roland
AU - Mudra, Harald
AU - Ledwoch, Jakob
AU - Menck, Niels
AU - Horstkotte, Jan
AU - Pels, Klaus
AU - Lahmann, Anna-Lena
AU - Otto, Sylvia
AU - Lenk, Karsten
AU - Ohlow, Marc-Alexander
AU - Hassager, Christian
AU - Nordbeck, Peter
AU - Zeymer, Uwe
AU - Jobs, Alexander
AU - de Waha-Thiele, Suzanne
AU - Olbrich, Denise
AU - König, Inke
AU - Klinge, Kathrin
AU - Thiele, Holger
PY - 2019/3
Y1 - 2019/3
N2 - Patients experiencing out-of-hospital cardiac arrest (OHCA) without ST-segment elevation are a heterogenic group with a variety of underlying causes. Up to one-third of patients display a significant coronary lesion compatible with myocardial infarction as OHCA trigger. There are no randomized data on patient selection and timing of invasive coronary angiography after admission. METHODS AND RESULTS: The TOMAHAWK trial randomly assigns 558 patients with return of spontaneous circulation after OHCA with no obvious extracardiac origin of cardiac arrest and no ST-segment elevation/left bundle-branch block on postresuscitation electrocardiogram to either immediate coronary angiography or initial intensive care assessment with delayed/selective angiography in a 1:1 ratio. The primary end point is 30-day all-cause mortality. Secondary analyses will be performed with respect to initial rhythm, electrocardiographic patterns, myocardial infarction as underlying cause, neurological outcome, as well as clinical and laboratory markers. Clinical follow-up will be performed at 6 and 12 months. Safety end points include bleeding and stroke. CONCLUSION: The TOMAHAWK trial will address the unresolved issue of timing and general indication of angiography after OHCA without ST-segment elevation.
AB - Patients experiencing out-of-hospital cardiac arrest (OHCA) without ST-segment elevation are a heterogenic group with a variety of underlying causes. Up to one-third of patients display a significant coronary lesion compatible with myocardial infarction as OHCA trigger. There are no randomized data on patient selection and timing of invasive coronary angiography after admission. METHODS AND RESULTS: The TOMAHAWK trial randomly assigns 558 patients with return of spontaneous circulation after OHCA with no obvious extracardiac origin of cardiac arrest and no ST-segment elevation/left bundle-branch block on postresuscitation electrocardiogram to either immediate coronary angiography or initial intensive care assessment with delayed/selective angiography in a 1:1 ratio. The primary end point is 30-day all-cause mortality. Secondary analyses will be performed with respect to initial rhythm, electrocardiographic patterns, myocardial infarction as underlying cause, neurological outcome, as well as clinical and laboratory markers. Clinical follow-up will be performed at 6 and 12 months. Safety end points include bleeding and stroke. CONCLUSION: The TOMAHAWK trial will address the unresolved issue of timing and general indication of angiography after OHCA without ST-segment elevation.
U2 - 10.1016/j.ahj.2018.12.005
DO - 10.1016/j.ahj.2018.12.005
M3 - Journal article
C2 - 30639610
SN - 0002-8703
VL - 209
SP - 20
EP - 28
JO - American Heart Journal
JF - American Heart Journal
ER -